Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sudipta Seal is active.

Publication


Featured researches published by Sudipta Seal.


Nature Nanotechnology | 2006

Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides

Junping Chen; Swanand Patil; Sudipta Seal; James F. McGinnis

Photoreceptor cells are incessantly bombarded with photons of light, which, along with the cells high rate of oxygen metabolism, continuously exposes them to elevated levels of toxic reactive oxygen intermediates (ROIs). Vacancy-engineered mixed-valence-state cerium oxide nanoparticles (nanoceria particles) scavenge ROIs. Our data show that nanoceria particles prevent increases in the intracellular concentrations of ROIs in primary cell cultures of rat retina and, in vivo, prevent loss of vision due to light-induced degeneration of photoreceptor cells. These data indicate that the nanoceria particles may be effective in inhibiting the progression of ROI-induced cell death, which is thought to be involved in macular degeneration, retinitis pigmentosa and other blinding diseases, as well as the ROI-induced death of other cell types in diabetes, Alzheimers disease, atherosclerosis, stroke and so on. The use of nanoceria particles as a direct therapy for multiple diseases represents a novel strategy and suggests that they may represent a unique platform technology.


Applied Physics Letters | 2005

Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide

Sameer Deshpande; Swanand Patil; Satyanarayana V N T Kuchibhatla; Sudipta Seal

A correlation between the particle size and the lattice parameter has been established in nanocerium oxide particles (3–30nm). The variation in the lattice parameter is attributed to the lattice strain induced by the introduction of Ce3+ due to the formation of oxygen vacancies. Lattice strain was observed to decrease with an increase in the particle size. Ce3+ ions concentration increased from 17% to 44% with the reduction in the particle size.


Biomaterials | 2008

The role of cerium redox state in the SOD mimetic activity of nanoceria

Eric Heckert; Ajay S. Karakoti; Sudipta Seal; William T. Self

Cerium oxide nanoparticles (nanoceria) have recently been shown to protect cells against oxidative stress in both cell culture and animal models. Nanoceria has been shown to exhibit superoxide dismutase (SOD) activity using a ferricytochrome C assay, and this mimetic activity that has been postulated to be responsible for cellular protection by nanoceria. The nature of nanocerias antioxidant properties, specifically what physical characteristics make nanoceria effective at scavenging superoxide anion, is poorly understood. In this study electron paramagnetic resonance (EPR) analysis confirms the reactivity of nanoceria as an SOD mimetic. X-ray photoelectron spectroscopy (XPS) and UV-visible analyses of nanoceria treated with hydrogen peroxide demonstrate that a decrease in the Ce 3(+)/4(+) ratio correlates directly with a loss of SOD mimetic activity. These results strongly suggest that the surface oxidation state of nanoceria plays an integral role in the SOD mimetic activity of nanoceria and that ability of nanoceria to scavenge superoxide is directly related to cerium(III) concentrations at the surface of the particle.


Chemical Communications | 2010

Nanoceria exhibit redox state-dependent catalase mimetic activity

Talib Pirmohamed; Janet M. Dowding; Sanjay Singh; Brian Wasserman; Eric Heckert; Ajay S. Karakoti; Jessica E. S. King; Sudipta Seal; William T. Self

In this study we have found that cerium oxide nanoparticles exhibit catalase mimetic activity. Surprisingly, the catalase mimetic activity correlates with a reduced level of cerium in the +3 state, in contrast to the relationship between surface charge and superoxide scavenging properties.


Small | 2009

Anti‐inflammatory Properties of Cerium Oxide Nanoparticles

Suzanne M. Hirst; Ajay S. Karakoti; Ron Tyler; Nammalwar Sriranganathan; Sudipta Seal; Christopher M. Reilly

The valence and oxygen defect properties of cerium oxide nanoparticles (nanoceria) suggest that they may act as auto-regenerative free radical scavengers. Overproduction of the free radical nitric oxide (NO) by the enzyme inducible nitric oxide synthase (iNOS) has been implicated as a critical mediator of inflammation. NO is correlated with disease activity and contributes to tissue destruction. The ability of nanoceria to scavenge free radicals, or reactive oxygen species (ROS), and inhibit inflammatory mediator production in J774A.1 murine macrophages is investigated. Cells internalize nanoceria, the treatment is nontoxic, and oxidative stress and pro-inflammatory iNOS protein expression are abated with stimulation. In vivo studies show nanoceria deposition in mouse tissues with no pathogenicity. Taken together, it is suggested that cerium oxide nanoparticles are well tolerated in mice and are incorporated into cellular tissues. Furthermore, nanoceria may have the potential to reduce ROS production in states of inflammation and therefore serve as a novel therapy for chronic inflammation.


Angewandte Chemie | 2011

PEGylated Inorganic Nanoparticles

Ajay S. Karakoti; Soumen Das; Suntharampillai Thevuthasan; Sudipta Seal

Application of inorganic nanoparticles in diagnosis and therapy has become a critical component in the targeted treatment of diseases. The surface modification of inorganic oxides is important for providing diversity in size, shape, solubility, long-term stability, and attachment of selective functional groups. This Minireview describes the role of polyethylene glycol (PEG) in the surface modification of oxides and focuses on their biomedical applications. Such a PEGylation of surfaces provides stealth characteristics to nanomaterials otherwise identified as foreign materials by human body. The role of PEG as structure-directing agent in synthesis of oxides is also presented.


Nanomedicine: Nanotechnology, Biology and Medicine | 2010

Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2

Jimmie Colon; Nelson Hsieh; Amber Ferguson; Patrick A. Kupelian; Sudipta Seal; D. Wayne Jenkins; Cheryl H. Baker

UNLABELLEDnThe ability of rare earth cerium oxide (CeO(2)) nanoparticles to confer radioprotection against gastrointestinal epithelium was examined. The pretreatment of normal human colon cells (CRL 1541) with varying concentrations of CeO(2) nanoparticles 24 hours before single-dose radiation exposure conferred protection from radiation-induced cell death by reducing the amount of reactive oxygen species produced and increasing the expression of superoxide dismutase 2 (SOD2), in a dose-dependent manner. In subsequent experiments athymic nude mice were pretreated with intraperitoneal injections of CeO(2) nanoparticles before a single dose of radiation to the abdominal area. Immunohistochemical analysis show a decrease in TUNEL- and caspase 3-positive cells in the colonic crypt, 4 hours after radiation. In sharp contrast, a significant increase in SOD2 expression was observed. In the end, these studies suggest that CeO(2) nanoparticles protect the gastrointestinal epithelium against radiation-induced damage by (1) acting as free-radical scavengers and (2) increasing the production of SOD2 before radiation insult.nnnFROM THE CLINICAL EDITORnIn this study, the ability of rare earth cerium oxide (CeO(2)) nanoparticles to confer radioprotection was examined. The results suggest that CeO(2) nanoparticles protect the gastrointestinal epithelium against radiation-induced damage both by acting as free-radical scavengers and by increasing the production of SOD2 before radiation insult.


Nanomedicine: Nanotechnology, Biology and Medicine | 2013

Cerium oxide nanoparticles: applications and prospects in nanomedicine.

Soumen Das; Janet M. Dowding; Kathryn Klump; James F. McGinnis; William T. Self; Sudipta Seal

Promising results have been obtained using cerium (Ce) oxide nanoparticles (CNPs) as antioxidants in biological systems. CNPs have unique regenerative properties owing to their low reduction potential and the coexistence of both Ce(3+)/Ce(4+) on their surfaces. Defects in the crystal lattice due to the presence of Ce(3+) play an important role in tuning the redox activity of CNPs. The surface Ce(3+):Ce(4+) ratio is influenced by the microenvironment. Therefore, the microenvironment and synthesis method adopted also plays an important role in determining the biological activity and toxicity of CNPs. The presence of a mixed valance state plays an important role in scavenging reactive oxygen and nitrogen species. CNPs are found to be effective against pathologies associated with chronic oxidative stress and inflammation. CNPs are well tolerated in both in vitro and in vivo biological models, which makes CNPs well suited for applications in nanobiology and regenerative medicine.


Nanomedicine: Nanotechnology, Biology and Medicine | 2013

Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production.

Melissa S. Wason; Jimmie Colon; Soumen Das; Sudipta Seal; James Turkson; Jihe Zhao; Cheryl H. Baker

UNLABELLEDnSide effect of radiation therapy (RT) remains the most challenging issue for pancreatic cancer treatment. In this report we determined whether and how cerium oxide nanoparticles (CONPs) sensitize pancreatic cancer cells to RT. CONP pretreatment enhanced radiation-induced reactive oxygen species (ROS) production preferentially in acidic cell-free solutions as well as acidic human pancreatic cancer cells. In acidic environments, CONPs favor the scavenging of superoxide radical over the hydroxyl peroxide resulting in accumulation of the latter whereas in neutral pH CONPs scavenge both. CONP treatment prior to RT markedly potentiated the cancer cell apoptosis both in culture and in tumors and the inhibition of the pancreatic tumor growth without harming the normal tissues or host mice. Taken together, these results identify CONPs as a potentially novel RT-sensitizer as well as protectant for improving pancreatic cancer treatment.nnnFROM THE CLINICAL EDITORnPancreatic tumors remain some of the most notoriously treatment-unresponsive malignancies. Cerium oxide nanoparticles may be capable of sensitizing such cells to radiotherapy, as demonstrated in this study.


Biomaterials | 2011

Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor–stroma interactions

Lirija Alili; Maren Sack; Ajay S. Karakoti; Sarah Teuber; Katharina Puschmann; Suzanne M. Hirst; Christopher M. Reilly; Klaus Zanger; Wilhelm Stahl; Soumen Das; Sudipta Seal; Peter Brenneisen

Tumor-stroma interaction plays an important role in tumor progression. Myofibroblasts, pivotal for tumor progression, populate the microecosystem of reactive stroma. The formation of myofibroblasts is mediated by tumor derived transforming growth factor β1 (TGFβ1) which initiates a reactive oxygen species cell type dependent expression of alpha-smooth muscle actin, a biomarker for myofibroblastic cells. Myofibroblasts express and secrete proinvasive factors significantly increasing the invasive capacity of tumor cells via paracrine mechanisms. Although antioxidants prevent myofibroblast formation, the same antioxidants increase the aggressive behavior of the tumor cells. In this study, the question was addressed of whether redox-active polymer-coated cerium oxide nanoparticles (CNP, nanoceria) affect myofibroblast formation, cell toxicity, and tumor invasion. Herein, nanoceria downregulate both the expression of alpha-smooth muscle actin positive myofibroblastic cells and the invasion of tumor cells. Furthermore, concentrations of nanoceria being non-toxic for normal (stromal) cells show a cytotoxic effect on squamous tumor cells. The treatment with redox-active CNP may form the basis for protection of stromal cells from the dominating influence of tumor cells in tumor-stroma interaction, thus being a promising strategy for chemoprevention of tumor invasion.

Collaboration


Dive into the Sudipta Seal's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Soumen Das

University of Central Florida

View shared research outputs
Top Co-Authors

Avatar

William T. Self

University of Central Florida

View shared research outputs
Top Co-Authors

Avatar

Janet M. Dowding

University of Central Florida

View shared research outputs
Top Co-Authors

Avatar

Swanand Patil

University of Central Florida

View shared research outputs
Top Co-Authors

Avatar

Jimmie Colon

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cheryl H. Baker

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Christopher M. Reilly

Edward Via College of Osteopathic Medicine

View shared research outputs
Top Co-Authors

Avatar

Eric Heckert

University of Central Florida

View shared research outputs
Researchain Logo
Decentralizing Knowledge